Abraham Lee
University of California Irvine, USA

Dr. Abraham “Abe” Lee received his Ph.D. from the University of California at Berkeley in 1992. He then joined the Lawrence Livermore National Laboratory as a Principal Investigator (1992- 1999). He became a Program Manager at the Defense Advanced Research Projects Agency (2/1999-6/2001) and a Senior Technology Advisor with the National Cancer Institute (4/2001 – 12/2001). Dr. Lee joined the Department of Biomedical Engineering at the University of California at Irvine (UCI) in 2002 and served as the Department Chair from 2010 through 2019. He is currently the Chancellor’s Professor at UCI.

Dr. Lee has a distinguished record of outstanding technical and leadership contributions. He has been a most welcomed speaker and was the recipient of the 2019 WACBE Savio L-Y. Woo Distinguished Lecture Award. He has received a large number of prestigious awards and medals including 2009 “Pioneers in Miniaturization” Award, arguably the most prestigious award in his field. He is a Fellow in the American Institute of Medical and Biological Engineering, the Royal Society of Chemistry, the Biomedical Engineering Society. In 2019, he was elected to the National Academy of Inventors.

Dr. Lee is an internationally renowned expert and leader in biomedical microfluidics and its biomedical applications, including liquid biopsy, cell therapy, single cell analysis, targeted therapeutics, and microphysiological systems. He has pioneered microscale tools, including MEMS, BioMEMS and microfluidics/Lab-on-a-Chip technologies. His work has inspired or resulted in commercialization through startups, technology transfer, and new technology that extends the impact of the Microfluidics and Lab on a Chip (LOC) fields.